IRF9 and Patent ductus arteriosus: IRF-9, a transcription factor that partners with activated STAT1/2 to mediate type I IFN responses and downstream IFN-stimulated genes expression (45), together with p-STAT2, was dramatically suppressed by JAKi in PDA cells upon CAR T cell challenge.